395 related articles for article (PubMed ID: 1871124)
1. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
Ray A; LaForge KS; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
Ray A; LaForge KS; Sehgal PB
Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715
[TBL] [Abstract][Full Text] [Related]
3. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of heat shock transcription factor by GR.
Wadekar SA; Li D; Periyasamy S; Sánchez ER
Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
[TBL] [Abstract][Full Text] [Related]
5. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
6. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock.
Sanchez ER; Hu JL; Zhong S; Shen P; Greene MJ; Housley PR
Mol Endocrinol; 1994 Apr; 8(4):408-21. PubMed ID: 8052262
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences.
Vacca A; Martinotti S; Screpanti I; Maroder M; Felli MP; Farina AR; Gismondi A; Santoni A; Frati L; Gulino A
J Biol Chem; 1990 May; 265(14):8075-80. PubMed ID: 2159467
[TBL] [Abstract][Full Text] [Related]
11. A steroid-inducible promoter for the controlled overexpression of cloned genes in eukaryotic cells.
Mader S; White JH
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5603-7. PubMed ID: 8390672
[TBL] [Abstract][Full Text] [Related]
12. Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors.
Liu W; Hillmann AG; Harmon JM
Mol Cell Biol; 1995 Feb; 15(2):1005-13. PubMed ID: 7823916
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element.
Pearce D; Yamamoto KR
Science; 1993 Feb; 259(5098):1161-5. PubMed ID: 8382376
[TBL] [Abstract][Full Text] [Related]
14. Two point mutations in the hormone-binding domain of the mouse glucocorticoid receptor that dramatically reduce its function.
Byravan S; Milhon J; Rabindran SK; Olinger B; Garabedian MJ; Danielsen M; Stallcup MR
Mol Endocrinol; 1991 Jun; 5(6):752-8. PubMed ID: 1922094
[TBL] [Abstract][Full Text] [Related]
15. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment.
Jee YK; Gilmour J; Kelly A; Bowen H; Richards D; Soh C; Smith P; Hawrylowicz C; Cousins D; Lee T; Lavender P
J Biol Chem; 2005 Jun; 280(24):23243-50. PubMed ID: 15826950
[TBL] [Abstract][Full Text] [Related]
16. A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation.
Ray A; Sassone-Corsi P; Sehgal PB
Mol Cell Biol; 1989 Dec; 9(12):5537-47. PubMed ID: 2511437
[TBL] [Abstract][Full Text] [Related]
17. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants.
de Lange P; Koper JW; Huizenga NA; Brinkmann AO; de Jong FH; Karl M; Chrousos GP; Lamberts SW
Mol Endocrinol; 1997 Jul; 11(8):1156-64. PubMed ID: 9212062
[TBL] [Abstract][Full Text] [Related]
18. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
Ramos RA; Meilandt WJ; Wang EC; Firestone GL
FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
[TBL] [Abstract][Full Text] [Related]
19. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.
Santhanam U; Ray A; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7605-9. PubMed ID: 1652755
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter.
Heinrichs AA; Bortell R; Rahman S; Stein JL; Alnemri ES; Litwack G; Lian JB; Stein GS
Biochemistry; 1993 Oct; 32(42):11436-44. PubMed ID: 8218210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
